Martin Tuchman

FTAI director Martin Tuchman sells ~254k shares (80% of holdings) for ~$61.5M as stock trades below 52-week highs.

Director Martin Tuchman executed a substantial three-tranche liquidation of roughly four-fifths of his stake in FTAI Aviation over just four trading days, raising approximately $61.5 million. The timing is notable: the stock is trading meaningfully below its recent highs, yet Tuchman chose to sell into this weakness rather than hold or wait for a recovery. This contrasts sharply with the company's improving operational profile—latest quarter showed profitability and strong revenue growth—which one might expect to give a director confidence to maintain or add to his position. The pattern suggests Tuchman may be prioritizing liquidity or portfolio rebalancing over conviction in near-term appreciation, or potentially signals caution about forward visibility despite recent earnings strength. The sale's size and deliberate pacing warrant attention from investors monitoring insider positioning, though the company's fundamentals do not show distress.

Director Martin Tuchman bought 3,056 shares over 2 days at $32.28 avg, raising stake 29% to 13,604 shares

Director Martin Tuchman made 2 separate purchases totaling 3,056 shares for $98,653.15 on consecutive days (2025-11-19 and 2025-11-20), acquiring shares at a blended average price of $32.28. This 29.0% increase in his stake follows a cluster of 5 prior buys at BPRN over the preceding week (2025-11-07 through 2025-11-18), suggesting sustained accumulation in the near term. The current price of $33.38 sits 8.4% above the 30-day average and -13.1% from the 52-week high, placing the purchase within recent upward momentum but well below the year's peak. While Tuchman's cross-ticker track record shows an 83.33% 90-day win rate with an avg 90d return of +5.3% across 20 prior buys, his same-ticker history at BPRN lacks measurable outcomes on the 5 recent trades, so prior performance does not yet establish a pattern at this specific name. Investors should monitor whether this multi-day accumulation reflects sustained conviction or represents part of a broader investment plan.

Director Martin Tuchman purchases 3,000 shares at avg $32.53, raising BPRN stake 39.7% to 10,548 shares

Martin Tuchman, a director at Princeton Bancorp, executed 2 separate open-market purchases totaling 3,000 shares for $97,600.00 on November 17–18, 2025, at prices between $32.00 and $32.30. This acquisition increased his shareholdings by 39.7% from 7,548 to 10,548 shares—a material concentration in his position. The purchases occurred while the stock trades at $32.25, only -16.0% below its 52-week high of $38.40 and up +5.8% over the past 30 days, suggesting the buying was not triggered by distressed valuations. Notably, Tuchman has accumulated 5 purchases at BPRN in rapid succession (November 5, 7, 11, 12, and 19), all still in their measurement window with no 90-day outcomes yet observable. His cross-ticker track record shows 20 prior buys with a 76.92% win rate at the 90-day mark, though timing success at this specific ticker remains to be demonstrated.

Director Martin Tuchman purchases 5,052 shares at $33.00 in 2 transactions, tripling stake to 7,548 shares at Princeton Bancorp (BPRN).

Martin Tuchman, a director at Princeton Bancorp, executed 2 separate purchases totaling 5,052 shares for $166,713.50 at a blended average price of $33.00 on November 11-12, 2025. This transaction increased his holdings by 202.4% from 2,496 to 7,548 shares, representing a material accumulation. His cross-ticker track record shows 71.43% win rate with average 90-day returns of +4.5%, though his 5 prior trades at BPRN lack measurable 90-day outcomes. The current stock price of $33.47 trades 14.0% below the 52-week high of $38.90 but reflects +8.3% momentum over the prior 30 days. With a P/E of 12.73 and market cap of $226,352,890.73, the company appears modestly valued.

Director Martin Tuchman buys 493 BPRN shares at $33.00; 4th buy in 8 days, holdings up 24.6%

TUCHMAN MARTIN purchased 493 shares of Princeton Bancorp at $33.00 on 2025-11-07, bringing his holdings to 2,496 shares and representing a 24.6% increase from his pre-transaction position of 2,003 shares. This purchase is part of an intense cluster: four additional buys at BPRN occurred between 2025-11-04 and 2025-11-12, all within an 8-day window. His cross-ticker track record across 20 prior open-market buys shows an average 90-day return of 5.0% with a 76.92% win rate, but his prior trades at BPRN provide limited forward-looking data—one measurable trade (2025-09-08 buy) showed a -6.4% 30-day return, and four recent buys remain unmeasured. The stock trades at a P/E of 12.52 with a 52-week high of $38.90, roughly 15.4% above the current price of $32.93, while the company reports net income of $6,466,000.00. The concentrated timing and volume of accumulation warrant examination to clarify whether this reflects a deliberate position-building strategy or responses to market conditions.

Director Martin Tuchman buys 10,000 BPRN shares at $33.00; holds 639,141 shares post-transaction, +1.6%.

TUCHMAN MARTIN purchased 10,000 shares at $33.00 on 2025-09-08, expanding his holdings to 639,141 shares. This represents the fourth consecutive buy of BPRN in less than two weeks (prior purchases on 2025-08-05, 08-06, 08-07, 08-19, and 08-20), establishing a repeated accumulation pattern. The buy occurred when BPRN was trading -15.7% from its 52-week high of $38.90, and the stock has appreciated +2.8% over the subsequent 30 days. His cross-ticker track record shows 20 prior buys with an average 90-day return of +3.4%, though his same-ticker history at BPRN (5 prior trades) shows no measurable 90-day outcomes yet. The company's P/E of 32.47 and market cap of $221.3M provide context, though recent fundamental strength (net income of $688.0K) is modest relative to valuation. The concentrated buying pattern near price lows warrants monitoring to establish whether sustained accumulation continues or resolves.

Director Martin Tuchman purchased 4,000 shares of BPRN at blended average $32.98 across two transactions (Aug 19–20), establishing initial position

Tuchman, a director at Princeton Bancorp, executed two separate purchases totaling 4,000 shares for $131,900.00 on 2025-08-19 and 2025-08-20 at prices of $32.90 and $33.00 respectively. This represents his first open-market stake at BPRN, following five prior buy transactions at the same ticker between 2025-08-01 and 2025-08-07, none of which yet have measurable 90-day outcomes. The current price of $33.11 sits 30.9% below the 52-week high of $38.90 and 19.5% above the 52-week low of $27.69. Across all his open-market history on other tickers, Tuchman's 20 prior buys averaged +1.6% return over 30 days and +1.3% over 90 days, with a 45.45% win rate. His serial purchases at BPRN, all concentrated in early August 2025, have not yet provided sufficient time for outcome measurement.

Director Martin Tuchman buys 1,000 shares of BPRN at $31.00, marking first open-market position after 4 purchases in 3 days

Martin Tuchman, a director of Princeton Bancorp, purchased 1,000 shares at $31.00 on 2025-08-07, establishing his first recorded position at this ticker. This transaction marks the fifth buy in a four-day window (2025-08-01 through 2025-08-07), suggesting repeated interest in the name at modest price variation. At the current price of $31.78, the stock is -18.3% from its 52-week high of $38.90, placing it in the lower half of its annual range. Across his cross-ticker history, Tuchman has executed 20 prior buys with a 90-day win rate of 36.36% and average 90-day return of -0.9%, indicating his purchases have not systematically outperformed. The rapid accumulation warrants observation to determine whether this represents conviction-driven positioning or reflects other timing drivers.

Director Martin Tuchman purchased 2,039 shares at blended average $30.90 on Aug 5-6; holds 122.8K shares post-transaction.

Director Martin Tuchman executed 2 separate purchases totaling 2,039 shares for $63,009.02 between Aug 5-6, 2025, at prices of $30.50 and $31.03, raising his holdings to 122.8K shares (a +1.7% increase). The stock currently trades at $31.66, near the transaction price and -18.6% from its 52-week high of $38.90. At BPRN specifically, Tuchman has completed 5 recent buy transactions since June 5, with two early-stage trades (June 5-6) showing 30-day returns of +7.8% and +7.2% respectively, though longer-term outcomes remain unmeasured. His cross-ticker track record shows 20 prior buys with a weak 30-day average of +0.2% and a 36.36% win rate at 90 days, providing limited signal about the predictive value of this purchase.

Director TUCHMAN MARTIN purchases 2,961 shares of BPRN at avg $30.12; stock down 21.4% from 52-week high.

TUCHMAN MARTIN executed 2 separate purchases totaling 2,961 shares for $89,197.40 across August 1–4, 2025, at prices near the current level ($30.12 blended vs. $30.73 current). His holdings increased 2.5% to 120,799 shares. The stock has declined 21.4% from its 52-week high of $39.12 and is down 5.9% over the last 30 days, trading below the insider's buy prices during early June. His prior four purchases at BPRN (June 3–6, 2025) each returned approximately 7–7.8% within 30 days; however, none of his historical buy transactions show a pattern of well-timed entry at the 90-day mark. The current price action suggests the stock remains in a period of relative weakness relative to recent highs, and no measurable outcome data is yet available for the August 1 and August 4 purchases.